BMO Capital Maintains Outperform on Phreesia, Lowers Price Target to $14
3/31/2026
Impact: -70
Healthcare
BMO Capital analyst Sean Dodge has maintained an Outperform rating on Phreesia (NYSE: PHR) but has lowered the price target from $32 to $14. This adjustment reflects a significant decrease in the expected valuation of the company.
AI summary, not financial advice
Share: